Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125672102 | 12567210 | 2 | F | 20160509 | 20160714 | 20160718 | 20160721 | EXP | RO-KADMON PHARMACEUTICALS, LLC-KAD201607-002558 | KADMON | 56.24 | YR | M | Y | 0.00000 | 20160721 | CN | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125672102 | 12567210 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | FILM-COATED TABLET, 2 IN THE MORNING AND 3 IN THE EVENING | 1054936 | 77456 | FILM-COATED TABLET | ||||||||
| 125672102 | 12567210 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | 1054936 | 77456 | |||||||||||
| 125672102 | 12567210 | 3 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | FILM-COATED TABLET | 1058724 | 0 | FILM-COATED TABLET | ||||||||
| 125672102 | 12567210 | 4 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 1058724 | 0 | |||||||||||
| 125672102 | 12567210 | 5 | SS | Exviera | DASABUVIR | 1 | Oral | FILM-COATED TABLET, 1 IN THE MORNING AND 1 IN THE EVENING | 1059064 | 0 | FILM-COATED TABLET | ||||||||
| 125672102 | 12567210 | 6 | SS | Exviera | DASABUVIR | 1 | 1059064 | 0 | |||||||||||
| 125672102 | 12567210 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | TABLET | 0 | TABLET | QOD | ||||||||
| 125672102 | 12567210 | 8 | C | Verospiron | SPIRONOLACTONE | 1 | Oral | 0 | |||||||||||
| 125672102 | 12567210 | 9 | C | Ursofalk | URSODIOL | 1 | Oral | TABLET | 0 | TABLET | BID | ||||||||
| 125672102 | 12567210 | 10 | C | Lagosa | 2 | Oral | TABLET | 0 | TABLET | BID | |||||||||
| 125672102 | 12567210 | 11 | C | Perindopril | PERINDOPRIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125672102 | 12567210 | 1 | Hepatitis C |
| 125672102 | 12567210 | 2 | Hepatic cirrhosis |
| 125672102 | 12567210 | 3 | Hepatitis C |
| 125672102 | 12567210 | 4 | Hepatic cirrhosis |
| 125672102 | 12567210 | 5 | Hepatitis C |
| 125672102 | 12567210 | 6 | Hepatic cirrhosis |
| 125672102 | 12567210 | 7 | Diuretic therapy |
| 125672102 | 12567210 | 8 | Diuretic therapy |
| 125672102 | 12567210 | 9 | Liver disorder |
| 125672102 | 12567210 | 10 | Liver disorder |
| 125672102 | 12567210 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125672102 | 12567210 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125672102 | 12567210 | Abdominal distension | |
| 125672102 | 12567210 | Diarrhoea | |
| 125672102 | 12567210 | Fatigue | |
| 125672102 | 12567210 | Oedema peripheral | |
| 125672102 | 12567210 | Oral herpes | |
| 125672102 | 12567210 | Pre-existing condition improved | |
| 125672102 | 12567210 | Therapeutic response unexpected | |
| 125672102 | 12567210 | Thirst |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125672102 | 12567210 | 1 | 20160509 | 0 | ||
| 125672102 | 12567210 | 3 | 20160509 | 0 | ||
| 125672102 | 12567210 | 5 | 20160509 | 0 | ||
| 125672102 | 12567210 | 7 | 20160628 | 0 | ||
| 125672102 | 12567210 | 8 | 20160628 | 0 | ||
| 125672102 | 12567210 | 9 | 2008 | 0 | ||
| 125672102 | 12567210 | 10 | 2008 | 0 | ||
| 125672102 | 12567210 | 11 | 20060520 | 0 |